|
Dec 4
|
TScan Therapeutics to Host Virtual KOL Event to Discuss Results from Ongoing Phase 1 Trial of TSC-100 and TSC-101 Presented at the 65th ASH Annual Meeting and Exposition
|
|
Dec 4
|
TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology Officer
|
|
Dec 1
|
Does TScan Therapeutics, Inc. (TCRX) Have the Potential to Rally 62.33% as Wall Street Analysts Expect?
|
|
Nov 30
|
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
|
|
Nov 28
|
With TScan Therapeutics Up 12%, Insider Buyers Count Their Returns
|
|
Nov 27
|
TScan Therapeutics, Inc. (TCRX) is a Great Momentum Stock: Should You Buy?
|
|
Nov 9
|
TScan Therapeutics Inc (TCRX) Reports Q3 2023 Financial Results and Corporate Updates
|
|
Nov 9
|
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 6
|
TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting
|
|
Aug 10
|
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Misses Revenue Estimates
|
|
Aug 10
|
TScan Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|